Vertex's diverse pipeline, including Casgevy for SCD, suzetrigine for chronic pain, and the vanzacaftor triple for CF, positions it for growth despite launch challenges. Casgevy's complex ...

The upgrade to the M4, the new 16GB RAM standard, the implementation of Thunderbolt across the board, the improved FaceTime camera, and the Nano-texture glass option are all winning moves by Apple.

Vertex has reported phase 3 data on its near-approval pain drug candidate suzetrigine, shedding light on how the non-opioid painkiller combines with ibuprofen and why the prospect failed to match ...

Vertex Pharmaceuticals is in the process of getting a new painkiller approved. It just published some data that suggests the candidate will be quite profitable. But regulators still need to sign ...

Google Cloud is enabling general availability for its Vertex AI platform in addition to new features for its Healthcare Data Engine (HDE), the company announced in a press release this morning.

Apple will release the new Mac mini, MacBook Pro, and iMac with the M4 chips tomorrow. After unveiling them through press releases last week, Cupertino sent journalists and influencers review ...

Apple’s new smaller Mac mini gives up very little after being hit with a shrink ray, and the M4 processors deliver great performance at a reasonable price. But that all turns sour the moment you ...

So when a business like Vertex Pharmaceuticals (NASDAQ: VRTX) releases some new data on a potential blockbuster that could be just a few months away from being approved for sale, it's a big ...

One common theme among reviews is that the base model M4 Macs, thanks to 16GB of RAM especially, are more compelling than ever. Where this is perhaps most surprising is the M4 MacBook Pro ...

Postmedia may earn an affiliate commission from purchases made through links on this page. The iMac M4 is a stunning desktop computer with a bright display, crisp speakers and a powerful chip ...

Vertex Pharmaceuticals again raised its full-year outlook after posting earnings and revenue growth in the third quarter. The biotechnology company on Monday posted a quarterly net profit of $1.05 ...